- Home
- INOD vs AUPH Comparison
INOD vs AUPH Comparison
Compare INOD & AUPH Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- INOD
- AUPH
- Stock Information
- Founded
- INOD 1988
- AUPH 1993
- Country
- INOD United States
- AUPH Canada
- Employees
- INOD N/A
- AUPH N/A
- Industry
- INOD EDP Services
- AUPH Biotechnology: Pharmaceutical Preparations
- Sector
- INOD Technology
- AUPH Health Care
- Exchange
- INOD Nasdaq
- AUPH Nasdaq
- Market Cap
- INOD 1.2B
- AUPH 1.1B
- IPO Year
- INOD 1993
- AUPH 1999
- Fundamental
- Price
- INOD $46.33
- AUPH $7.92
- Analyst Decision
- INOD Strong Buy
- AUPH Strong Buy
- Analyst Count
- INOD 4
- AUPH 2
- Target Price
- INOD $57.50
- AUPH $11.50
- AVG Volume (30 Days)
- INOD 2.5M
- AUPH 1.1M
- Earning Date
- INOD 08-07-2025
- AUPH 07-31-2025
- Dividend Yield
- INOD N/A
- AUPH N/A
- EPS Growth
- INOD 1293.88
- AUPH N/A
- EPS
- INOD 1.08
- AUPH 0.27
- Revenue
- INOD $202,301,000.00
- AUPH $247,295,000.00
- Revenue This Year
- INOD $44.28
- AUPH $12.15
- Revenue Next Year
- INOD $21.27
- AUPH $18.31
- P/E Ratio
- INOD $43.05
- AUPH $29.77
- Revenue Growth
- INOD 114.21
- AUPH 29.20
- 52 Week Low
- INOD $12.67
- AUPH $5.20
- 52 Week High
- INOD $71.00
- AUPH $10.67
- Technical
- Relative Strength Index (RSI)
- INOD 57.83
- AUPH 43.79
- Support Level
- INOD $39.15
- AUPH $8.08
- Resistance Level
- INOD $51.79
- AUPH $8.29
- Average True Range (ATR)
- INOD 4.24
- AUPH 0.19
- MACD
- INOD -0.03
- AUPH -0.02
- Stochastic Oscillator
- INOD 60.78
- AUPH 26.32
About INOD Innodata Inc.
Innodata Inc is a data engineering company. It is helping companies deploy and integrate AI into their operations and products and providing AI-enabled industry platforms. The Company's operations are classified in three reporting segments: Digital Data Solutions (DDS), Synodex and Agility. Key revenue is generated from DDS segment provides AI data preparation services, collecting or creating training data, annotating training data, and training AI algorithms for its customers, and AI model deployment and integration. It also provides a range of data engineering support services including data transformation, data curation, data hygiene, data consolidation, data extraction, data compliance, and master data management.
About AUPH Aurinia Pharmaceuticals Inc
Aurinia Pharmaceuticals Inc is a biopharmaceutical company focused on delivering therapies to people living with autoimmune diseases with high unmet medical needs. The company developed LUPKYNIS (voclosporin), the first FDA-approved oral therapy for the treatment of adult patients with active lupus nephritis. It is also developing AUR200, a dual inhibitor of B cell activating factor (BAFF) and a proliferation-inducing ligand (APRIL), for the potential treatment of autoimmune diseases.